Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of Burkholderia cepacia complex and Burkholderia gladioli in the clinical microbiology laboratory
Introduction.Burkholderia cepacia complex (Bcc) bacteria, currently consisting of 23 closely related species, and Burkholderia gladioli, can cause serious and difficult-to-treat infections in people with cystic fibrosis. Identifying Burkholderia bacteria to the species level is considered important for understanding epidemiology and infection control, and predicting clinical outcomes. Matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF) is a rapid method recently introduced in clinical laboratories for bacterial species-level identification. However, reports on the ability of MALDI-TOF to accurately identify Bcc to the species level are mixed.
Aim. The aim of this project was to evaluate the accuracy of MALDI-TOF using the Biotyper and VITEK MS systems in identifying isolates from 22 different Bcc species and B. gladioli compared to recA gene sequencing, which is considered the current gold standard for Bcc.
Methodology. To capture maximum intra-species variation, phylogenetic trees were constructed from concatenated multi-locus sequence typing alleles and clustered with a novel k-medoids approach. One hundred isolates representing 22 Bcc species, plus B. gladioli, were assessed for bacterial identifications using the two MALDI-TOF systems.
Results. At the genus level, 100 and 97.0 % of isolates were confidently identified as Burkholderia by the Biotyper and VITEK MS systems, respectively; moreover, 26.0 and 67.0 % of the isolates were correctly identified to the species level, respectively. In many, but not all, cases of species misidentification or failed identification, a representative library for that species was lacking.
Conclusion. Currently available MALDI-TOF systems frequently do not accurately identify Bcc bacteria to the species level.
This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
MartinaP,
LeguizamonM,
PrietoCI,
SousaSA,
MontanaroP et al.Burkholderia puraquae sp. nov., a novel species of the Burkholderia cepacia complex isolated from hospital settings and agricultural soils. Int J Syst Evol Microbiol2018; 68:14–20 [View Article]
BachE,
Sant'AnnaFH,
Magrich dos PassosJF,
BalsanelliE,
de BauraVA et al. Detection of misidentifications of species from the Burkholderia cepacia complex and description of a new member, the soil bacterium Burkholderia catarinensis sp. nov. Pathog Dis2017; 75: [View Article]
De SmetB,
MayoM,
PeetersC,
ZlosnikJEA,
SpilkerT et al.Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol2015; 65:2265–2271 [View Article]
De SoyzaA,
MeacheryG,
HesterKLM,
NicholsonA,
ParryG et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. The Journal of Heart and Lung Transplantation2010; 29:1395–1404 [View Article]
VandammeP,
DawyndtP.
Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst Appl Microbiol2011; 34:87–95 [View Article]
van BelkumA,
WelkerM,
PincusD,
CharrierJ-P,
GirardV.
Matrix-Assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: what are the current issues?. Ann Lab Med2017; 37:475–483 [View Article]
FehlbergLCC,
AndradeLHS,
AssisDM,
PereiraRHV,
GalesAC et al. Performance of MALDI-TOF MS for species identification of Burkholderia cepacia complex clinical isolates. Diagn Microbiol Infect Dis2013; 77:126–128 [View Article]
SinghalN,
KumarM,
KanaujiaPK,
VirdiJS.
Maldi-Tof mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol2015; 6:791 [View Article]
WattalC,
OberoiJK,
GoelN,
RaveendranR,
KhannaS.
Matrix-Assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory. Eur J Clin Microbiol2017; 36:807–812 [View Article]
De DiosJ,
MartínezCL,
TatoM,
MorosiniMI,
CoboM et al. Comparison between MALDI-TOF and recA gene sequencing for the identification of Burkholderia cepacia complex species isolated in a cystic fibrosis unit. Journal of Cystic Fibrosis2016; 15:S75 [View Article]
GautamV,
SharmaM,
SinghalL,
KumarS,
KaurP et al. Maldi-Tof mass spectrometry: an emerging tool for unequivocal identification of non-fermenting gram-negative bacilli. The Indian Journal of Medical Research2017; 145:665–672
AlbyK,
GilliganPH,
MillerMB.
Comparison of matrix-assisted laser desorption Ionization–Time of flight (MALDI-TOF) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis. J Clin Microbiol2013; 51:3852–3854 [View Article]
KennaDTD,
LilleyD,
CowardA,
MartinK,
PerryC et al. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J Med Microbiol2017; 66:490–501 [View Article]
WeberCF,
KingGM.
Volcanic soils as sources of novel CO-oxidizing Paraburkholderia and Burkholderia: Paraburkholderia hiiakae sp. nov., Paraburkholderia metrosideri sp. nov., Paraburkholderia paradisi sp. nov., Paraburkholderia peleae sp. nov., and Burkholderia alpina sp. nov. a member of the Burkholderia cepacia complex. Front Microbiol2017; 8:207 [View Article]
PeetersC,
ZlosnikJEA,
SpilkerT,
HirdTJ,
LiPumaJJ et al. Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol2013; 36:483–489 [View Article]
JolleyKA,
BrayJE,
MaidenMCJ.
Open-Access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Research2018; 3:124 [View Article]
BaldwinA,
MahenthiralingamE,
ThickettKM,
HoneybourneD,
MaidenMCJ et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol2005; 43:4665–4673 [View Article]
JombartT,
BallouxF,
DrayS.
adephylo: new tools for investigating the phylogenetic signal in biological traits. Bioinformatics2010; 26:1907–1909 [View Article]
MaechlerM,
RousseeuwP,
StruyfA,
HubertM,
HornikK et al. Cluster. R; 2019
KassambaraA,
MundtF.
factoextra; 2017
YuG,
SmithDK,
ZhuH,
GuanY,
LamTommy Tsan‐Yuk.
ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol2017; 8:28–36 [View Article]
CoenyeT,
LiPumaJJ,
HenryD,
HosteB,
VandemeulebroeckeK et al.Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol2001; 51:271–279 [View Article]
CoenyeT,
MahenthiralingamE,
HenryD,
LiPumaJJ,
LaevensS et al.Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol2001; 51:1481–1490 [View Article]
VandammeP,
HenryD,
CoenyeT,
NzulaS,
VancanneytM et al.Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunology and Medical Microbiology2002; 33:143–149 [View Article]
VanlaereE,
BaldwinA,
GeversD,
HenryD,
De BrandtE et al. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol2009; 59:102–111 [View Article]
ZlosnikJEA,
ZhouG,
BrantR,
HenryDA,
HirdTJ et al.Burkholderia species infections in patients with cystic fibrosis in british Columbia, Canada. 30 Years’ experience. Ann Am Thorac Soc2015; 12:70–78 [View Article]
DrevinekP,
MahenthiralingamE.
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clinical Microbiology and Infection2010; 16:821–830 [View Article]
QuonBS,
ReidJD,
WongP,
WilcoxPG,
JaverA et al.Burkholderia gladioli – A predictor of poor outcome in cystic fibrosis patients Who receive lung transplants? A case of locally invasive rhinosinusitis and persistent bacteremia in a 36-year-old lung transplant recipient with cystic fibrosis. Can Respir J2011; 18:e64–e65 [View Article]
MurrayS,
CharbeneauJ,
MarshallBC,
LiPumaJJ.
Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med2008; 178:363–371 [View Article]
FlorioW,
TavantiA,
BarniniS,
GhelardiE,
LupettiA.
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry. Front Microbiol2018; 9:1097 [View Article]
PlonglaR,
PanageaT,
PincusDH,
JonesMC,
GilliganPH.
Identification of Burkholderia and uncommon glucose-nonfermenting gram-negative bacilli isolated from patients with cystic fibrosis by use of matrix-assisted laser desorption Ionization–Time of flight mass spectrometry (MALDI-TOF MS). J Clin Microbiol2016; 54:3071–3072 [View Article]
VijayakumarS,
BiswasI,
VeeraraghavanB.
Accurate identification of clinically important Acinetobacter spp.: an update. Future Sci OA2019; 5:FSO395 [View Article]
PapaliaM,
SteffanowskiC,
TragliaG,
AlmuzaraM,
MartinaP et al. Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina. Revista Argentina de Microbiología2019S0325754119300483
ŠedoO,
Radolfová-KřížováL,
NemecA,
ZdráhalZ.
Limitations of routine MALDI-TOF mass spectrometric identification of Acinetobacter species and remedial actions. J Microbiol Methods2018; 154:79–85
Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of Burkholderia cepacia complex and Burkholderia gladioli in the clinical microbiology laboratory